SKVI · All filings · Read this filing

What changed 10-Q

Item 5. Other Information

2024-05-15 compared with 2023-11-15 · 8 added, 7 removed, 8 unchanged (65% of the section changed)

Other Information

Number Description of Exhibit

Exhibit Number Description of Exhibit

Certification of Chief Executive Officer pursuant to 18 U.S.C.

4 unchanged sentences

Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

following materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 formatted in

Extensible Business Reporting Language (XBRL).

to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by

the undersigned thereunto duly authorized.

November 14, 2023

The following materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 formatted in Extensible Business Reporting Language (XBRL).

**Provided herewith

Pursuant to the requirements of the Securities

Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Skinvisible, Inc.

/s/ Terry Howlett

Chief Executive Officer, Chief Financial Officer and Director

Terry Howlett

Chief Executive Officer, Chief Financial Officer and

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.